Continuous renal replacement therapy in the critically ill patient

Kidney International

Volumn 67, Issue 2, 2005, Pages 781-795

  Mehta, Ravindra L ^a,d   Harrington, John T ^b   Gabbai, Francis B ^c   Steiner, Robert W ^c   Fernandez, Rodrigo J ^a   Cunard, Robyn ^a   Smiley, Clayton ^a   Shah, Mita ^a   Rowder, Nicholas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UCSD MEDICAL CENTER   (United States)

Author keywords

Acute renal failure; Hemodiafiltration; Hemodialysis

Indexed keywords

ACETYLSALICYLIC ACID; AZITHROMYCIN; BETA 2 MICROGLOBULIN; CALCIUM; ETHAMBUTOL; FLUCONAZOLE; FLUTICASONE; FUROSEMIDE; INULIN; LAMIVUDINE; LOPINAVIR; PAROXETINE; RITONAVIR; SULFAMETHOXAZOLE; TENOFOVIR; TRAZODONE; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANAMNESIS; ASTHMA; BETA 2 MICROGLOBULIN URINE LEVEL; CASE REPORT; COGNITIVE DEFECT; CRITICAL ILLNESS; DEMENTIA; FEMALE; FLUID BALANCE; HEMODIALYSIS; HEMOFILTRATION; HEROIN DEPENDENCE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INULIN CLEARANCE; KIDNEY TRANSPLANTATION; LABORATORY TEST; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PNEUMOCYSTOSIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; ULTRAFILTRATION; UREA NITROGEN BLOOD LEVEL;

EID: 12344278980     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.67140.x     Document Type: Article

References (87)

1. HOFFMAN JN, HARTLE WH, DEPPISCH R, et al: Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22:1360-1367, 1996
2. GROOTENDORST AF, VAN BOMMEL EF, VAN DER HOVEN B, et al: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18:235-240, 1992
3. SIEGLER MH: Continuous arteriovenous hemodialysis. An improved technique for treating acute renal failure in critically ill patients, in Clinical Dialysis, edited by Nissenson AR, Gentile DR, Norwalk, CT, Appleton and Lange, 1989, pp 730-734
4. SIGLER MH, TEEHAN BP: Solute transport in continuous hemodialysis: A new treatment for acute renal failure. Kidney Int 32:562-571, 1987
5. TETTA C, RONCO C, BRENDOLAN A, et al: Present and future options in continuous renal replacement therapies of sepsis and MOF. Minerva Anestesiol 65:419-426, 1999
6. TROYANOV S, CARDINAL J, GEADAH D, et al: Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters. Nephrol Dial Transplant 18:961-966, 2003
7. GOLFER TA: Update on drug sieving coefficients after dosing adjustments during continuous renal replacement therapies. Contrib Nephrol 349-353, 2001
8. BOHLER J, DONAUER J, KELLER F: Pharmacokinetic principles during continuous renal replacement therapy: Drugs and dosage. Kidney Int (Suppl 72):S24-S28, 1999
9. BUGGE JF: Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients. Acta Anaesthesiol Scand 45:929-934, 2001
10. CLARK WR, TURK JE, KRAUS MA, GAO D: Dose determinants in continuous renal replacement therapy. Artif Organs 27:815-820, 2003
11. GARRED L, CANAUD B: Urea kinetic modeling for CRRT. Am J Kidney Dis 30:S2-S9, 1997
12. SIEBERTH HG, KIERDORF HP: Is cytokine removal by continuous hemofiltration feasible? Kidney Int (Suppl 72):S79-S83, 1999
13. HOFFMANN JN, HARTL WH, DEPPISCH R, et al: Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int 48:1563-1570, 1995
14. DE VRIESE AS, COLARDYN FA, PHILIPPE JJ, et al: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 10:846-853, 1999
15. LIAO Z, HARDY PA, POH CK, et al: Kinetic comparison of different acute dialysis therapies. Artif Organs 27:802-807, 2003
16. PAGANINI EP, BEDNARZ D: Dialysis delivery in the ICU-Are patients receiving the prescribed dialysis dose? J Am Soc Nephrol 3:384, 1992
17. ABDEEN O, MEHTA RL: Dialysis modalities in the intensive care unit. Crit Care Clin 18:223-247, 2002
18. MEHTA RL: Fluid management in CRRT. Contrib Nephrol 132:335-348, 2001
19. MACIAS WL, CLARK WR: Acid base balance in continuous renal replacement therapy. Semin Dial 9:145-151, 1996
20. SIGLER MH: Transport characteristics of the slow therapies: Implications for achieving adequacy of dialysis in acute renal failure. Adv Ren Replace Ther 4:68-80, 1997
21. MEHTA RL: Continuous renal replacement therapies in the acute renal failure setting: Current concepts. Adv Ren Replace Ther 4:81-92, 1997
22. MACIAS W: Choice of replacement fluid/dialysate anion in continuous renal replacement therapy. Am J Kidney Dis 28(Suppl 3):S15-S20, 1996
23. MEHTA RL, MCDONALD BR, AGUILAR MM, WARD DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976-981, 1990
24. LEVRAUT J, CIEBIERA JP, JAMBOU P, et al: Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med 25:58-62, 1997
25. HILTON PJ, TAYLOR J, FORNI LG, TREACHER DF: Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis. QJM 91:279-283, 1998
26. THOMAS AN, GUY JM, KISHEN R, et al: Comparison of lactate and bicarbonate buffered haemofiltration fluids: Use in critically ill patients. Nephrol Dial Transplant 12:1212-1217, 1997
27. BENJAMIN E: Continuous venvenous hemofiltration with dialysis and lactate clearance in critically ill paitents. Crit Care Med 25:4-5, 1997
28. HEERING P, IVENS K, THUMER O, et al: The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure. Intensive Care Med 25:1244-1251, 1999
29. HEERING P, IVENS K, THUMER O, et al: Acid-base balance and substitution fluid during continuous hemofiltration. Kidney Int (Suppl 72):S37-S40, 1999
30. BARENBROCK M, HAUSBERG M, MATZKIES F, et al: Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 58:1751-1757, 2000
31. KIERDORF H, LEUE C, ARNS S, et al: Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies. Kidney Int 56, suppl 72:S32-S36, 1999
32. LEBLANC M, MORENO L, ROBINSON O, et al: Bicarbonate dialysate for continuous renal replacement therapy in intensive care unit patients with acute renal failure. Am J Kidney Dis 26:910-917, 1995
33. SCHWAB G: Rapid production of bicarbonate-based dialysate for continuous veno-venous hemodiafiltration. Blood Purif 17:27-31, 1999
34. KANAGASUNDARAM NS, LARIVE AB, PAGANINI EP: A preliminary survey of bacterial contamination of the dialysate circuit in continuous veno-venous hemodialysis. Clin Nephrol 59:47-55, 2003
35. MACCARIELLO ER, BOECHAT L, PAGANI JR, et al: Single bag bicarbonate solutions in CRRT: Is that safe? Blood Purif 17:27, 1999
36. PALSSON R, NILES JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55:1991-1997, 1999
37. KUTSOGIANNIS DJ, MAYERS I, CHIN WD, GIBNEY RT: Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 35:802-811, 2000
38. ELHANAN N, SKIPPEN P, NUTHALL G, et al: Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol 19:208-212, 2004
39. MONCHI M, BERGHMANS D, LEDOUX D, et al: Citrate versus heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 30:260-265, 2004
40. MANNS M, SIGLER MH, TEEHAN BP: Intradialytic renal haemodynamics- Potential consequences for the management of the patient with acute renal failure. Nephrol Dial Transplant 12:870-872, 1997
41. ALEXOPOULOS E, VAKIANIS P, KOKOLINA E, et al: Acute renal failure in a medical setting: Changing patterns and prognostic factors. Ren Fail 16:273-284, 1994
42. MANNS M, SIGLER MH, TEEHAN BP: Continuous renal replacement therapies: An update. Am J Kidney Dis 32:185-207, 1998
43. CONGER J: Does hemodialysis delay recovery from acute renal failure? Semin Dial 3:146-150, 1990
44. SOLEZ K: The morphology of acute tubular necrosis in man: Analysis of 57 renal biopsies and comparison with the glycerol model. Medicine 58:362-367, 1979
45. STAR RA: Treatment of acute renal failure. Kidney Int 54:1817-1831, 1998
46. PAGANANI E: Dialysis is not dialysis is not dialysis! Acute dialysis is different and needs help! Am J Kidney Dis 32:832-833, 1998
47. BELLOMO R, RONCO CS: Indications and criteria for initiating renal replacement therapy in the intensive care unit. Kidney Int (Suppl 66):S106-S109, 1998
48. FERIANI M, DELL'AQUILA R: Acid-base balance and replacement solutions in continuous renal replacement therapies. Kidney Int (Suppl 66):S156-S159, 1998
49. SCHETZ M: Non-renal indications for continuous renal replacement therapy. Kidney Int (Suppl 72):S88-S94, 1999
50. RONCO C: Extracorporeal therapies: Should we use plasma instead of blood? Int J Artif Organs 22:342-346, 1999
51. TETTA C, BELLOMO R, FORMICA M, et al: Use of adsorbents in ARF therapy. Contrib Nephrol 137:181-188, 2002
52. HUMES HD, FISSELL WH, WEITZEL WF: The bioartificial kidney in the treatment of acute renal failure. Kidney Int (Suppl 80):121-125, 2002
53. MARSHALL MR, GOLPER TA, SHAVER MJ, CATOTH DK: Hybrid renal replacement modalities for the critically ill. Contrib Nephrol 132:252-257, 2001
54. KAPOOR D, WILLIAMS R, JALAN R: MARS: A new treatment for hepatorenal failure. Molecular adsorbent and recirculating system. Gastroenterology 119:1799-1800, 2000
55. SEN S, YTREBO LM, ROSE C, et al: Albumin dialysis: A new therapeutic strategy for intoxication from protein-bound drugs. Intensive Care Med 30:496-501, 2004
56. RONCO C, BELLOMO R, LONNEMAN G: Sepsis-Theory and therapies. N Engl J Med 348:1600-1602, 2003
57. DRUML W: Nonrenal indications for continuous hemofiltration therapy in patients with normal renal function. Contrib Nephrol 116:121-129, 1995
58. GALLA JH: Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. Renal Physicians Association/American Society of Nephrology Working Group. J Am Soc Nephrol 11:2, 1788, 2000
59. SILVESTER W, BELLOMO R, COLE L: Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 29:1910-1915, 2001
60. MEHTA RL, MCDONALD B, GABBAI FB, et al: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60:1154-1163, 2001
61. PRENDERGAST TJ: Resolving conflicts surrounding end-of-life care. New Horiz 5:62-71, 1997
62. MEHTA R: Acute renal failure in the intensive care unit: Which outcomes should we measure? Am J Kidney Dis 28:74-79, 1996
63. TONELLI M, MANNS B, FELLER-KOPMAN D: Acute renal failure in the intensive care unit: A systemic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40:875-885, 2002
64. KELLUM JA, ANGUS DC, JOHNSON JP, et al: Continuous versus intermittent renal replacement therapy: A meta-analysis. Intensive Care Med 28:29-37, 2002
65. MEHTA RL, CHERTOW GM: In critically ill patients with acute renal failure, outcomes, not dollars, should drive modality choice. Crit Care Med 31:644-646, 2003
66. MANNS B, DOIG CJ, LEE H, et al: Cost of acute renal failure requiring dialysis in the intensive care unit: Clinical and resource implications of renal recovery. Crit Care Med 31:449-455, 2003
67. RONCO C, BELLOMO R, HOMEL P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomized trial. Lancet 355:26-30, 2000
68. ABICHANDANI R, PEREIRA BJ: Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: A prospective randomized trial, by Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, LaGreca G. Semin Dial 14:233-234, 2001
69. PAGANINI EP, DEPNER T, WENSLEY D: The acute dialysis quality initiative-Part III: Solute control (treatment dose). Adv Ren Replace Ther 9:260-264, 2002
70. MEHTA RL, LETTERI JM: Current status of renal replacement therapy for acute renal failure. A survey of US nephrologists. The National Kidney Foundation Council on Dialysis. Am J Nephrol 19:377-382, 1999
71. MEHTA RL: Indications for dialysis in the ICU: Renal replacement versus renal support. Blood Purif 19:227-232, 2001
72. MENDELSSOHN DC, MULLANEY SR, JURG B, et al: What do American nephrologists think about dialysis modality selection? Am J Kidney Dis 37:22-29, 2001
73. KELLUM JA, MEHTA RL, ANGUS DC, et al: The first international consensus conference on continuous renal replacement therapy. Kidney Int 62:1855-1863, 2002
74. RONCO C, BRENDOLAN A, DAN M, et al: Machines for continuous renal replacement therapy. Contrib Nephrol 132:323-334, 2001
75. RONCO C, BALLESTRI M, BRENDOLAN A: New developments in hemodialyzers. Blood Purif 18:267-275, 2000
76. MORGERA S, SLOWINSKI T, MELZER C, et al: Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 43:444-453, 2004
77. BALDWIN I: Keeping pace with changes in technology and technique. Blood Purif 20:269-274, 2002
78. RONCO CBA, BELLOMO R: Online monitoring in continuous renal replacement therapies. Kidney Int 72:S8-S14, 1999
79. MEHTA RL, CHERTOW GM: Acute renal failure definitions and classifications: Time for change? J Am Soc Nephrol 14:2178-2187, 2003
80. FRANKENFIELD DC, REYNOLDS HN, BADELLINO MM, WILES CE 3RD: Glucose dynamics during continuous hemodiafiltration and total parenteral nutrition. Intensive Care Med 21:1016-1022, 1995
81. BELLOMO R, SEACOMBE J, DASKALAKIS M, et al: A prospective comparative study of moderate versus high protein intake for critically ill patients with acute renal failure. Ren Fail 19:111-120, 1997
82. PRONOVOST PJ, ANGUS DC, DORMAN T, et al: Physician staffing patterns and clinical outcomes in critically ill patients: a systemic review. JAMA 17:2151-2162, 2002
83. WRIGHT SE, BODENHAM A, SHORT AIK, TURNEY JH: The provision and practice of renal replacement therapy on adult intensive care units in the United Kingdom. Anaesthesia 58:1063-1069, 2003
84. VAN DEN BERGE G, WOUTERS P, WEEKERS F: Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359-1367, 2001
85. BELLOMO R, COLMAN PG, CAUDWELL J, BOYCE N: Acute continuous hemofiltration with dialysis: Effect on insulin concentrations and glycemic control in critically ill patients. Crit Care Med 20:1672-1672, 1992
86. SHEALY CB, CAMPBELL RC, HEY JC, et al: 24-hr creatinine clearance as a guide for CRRT withdrawal: A retrospective study. Blood Purif 21:192, 2003
87. MEHTA R: Renal replacement therapy for acute renal failure: Matching the method to the patient. Semin Dial 6:253-259, 1993